These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19125423)

  • 1. Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative.
    Jutooru I; Chadalapaka G; Chintharlapalli S; Papineni S; Safe S
    Mol Carcinog; 2009 Aug; 48(8):692-702. PubMed ID: 19125423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
    Papineni S; Chintharlapalli S; Safe S
    Mol Pharmacol; 2008 Feb; 73(2):553-65. PubMed ID: 17989348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
    Chintharlapalli S; Papineni S; Jutooru I; McAlees A; Safe S
    Mol Cancer Ther; 2007 May; 6(5):1588-98. PubMed ID: 17513608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
    Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
    Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor.
    Pang X; Zhang L; Wu Y; Lin L; Li J; Qu W; Safe S; Liu M
    J Pharmacol Exp Ther; 2010 Oct; 335(1):172-9. PubMed ID: 20631299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GW1929 inhibits α7 nAChR expression through PPARγ-independent activation of p38 MAPK and inactivation of PI3-K/mTOR: The role of Egr-1.
    Hahn SS; Tang Q; Zheng F; Zhao S; Wu J
    Cell Signal; 2014 Apr; 26(4):730-9. PubMed ID: 24412748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDODA-Me decreases specificity protein transcription factors and induces apoptosis in bladder cancer cells through induction of reactive oxygen species.
    Takeuchi H; Taoka R; Mmeje CO; Jinesh GG; Safe S; Kamat AM
    Urol Oncol; 2016 Aug; 34(8):337.e11-8. PubMed ID: 27038699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins.
    Chintharlapalli S; Papineni S; Lee SO; Lei P; Jin UH; Sherman SI; Santarpia L; Safe S
    Mol Carcinog; 2011 Sep; 50(9):655-67. PubMed ID: 21268135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
    Chintharlapalli S; Papineni S; Baek SJ; Liu S; Safe S
    Mol Pharmacol; 2005 Dec; 68(6):1782-92. PubMed ID: 16155208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
    Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
    J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4.
    Min KW; Zhang X; Imchen T; Baek SJ
    Toxicol Appl Pharmacol; 2012 Sep; 263(2):225-32. PubMed ID: 22750490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells.
    Chen YL; Lin PC; Chen SP; Lin CC; Tsai NM; Cheng YL; Chang WL; Lin SZ; Harn HJ
    J Pharmacol Exp Ther; 2007 Nov; 323(2):746-56. PubMed ID: 17715378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism.
    Shim M; Eling TE
    Mol Cancer Ther; 2008 Apr; 7(4):961-71. PubMed ID: 18413810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
    Chintharlapalli S; Papineni S; Liu S; Jutooru I; Chadalapaka G; Cho SD; Murthy RS; You Y; Safe S
    Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
    Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S
    Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation.
    Woo SM; Min KJ; Kim S; Park JW; Kim DE; Chun KS; Kim YH; Lee TJ; Kim SH; Choi YH; Chang JS; Kwon TK
    Chem Biol Interact; 2014 Mar; 211():36-43. PubMed ID: 24440808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
    Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S
    Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells.
    Shim M; Eling TE
    J Biol Chem; 2005 May; 280(19):18636-42. PubMed ID: 15757899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSP90 inhibitors induce desensitization of EGF receptor via p38 MAPK-mediated phosphorylation at Ser1046/1047 in human pancreatic cancer cells.
    Adachi S; Yasuda I; Nakashima M; Yamauchi T; Yamauchi J; Natsume H; Moriwaki H; Kozawa O
    Oncol Rep; 2010 Jun; 23(6):1709-14. PubMed ID: 20428829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.